| | DRINKING WATER CRITERIA DOCUMENT FOR CHLORAMINES |
| | 2,02 | | MB |
| | 155 | | stron |
| | 5908 | | ID | UNITED STATES ENVIRONMENTAL PROTECTION AGENCY |
| | 2002 | | rok |
| | TABLE OF CONTENTS |
| | I. SUMMARY I-1 |
| | II. PHYSICAL AND CHEMICAL PROPERTIES . II-1 |
| | INTRODUCTION II-1 |
| | PHYSICAL AND CHEMICAL PROPERTIES OF CHLORAMINES II-2 |
| | USES OF CHLORAMINES II-11 |
| | ANALYTICAL METHODS . II-12 |
| | ENVIRONMENTAL FATE AND TRANSPORT . II-16 |
| | SUMMARY II-17 |
| | III. TOXICOKINETICS III-1 |
| | INTRODUCTION III-1 |
| | ABSORPTION III-1 |
| | DISTRIBUTION . III-2 |
| | METABOLISM III-6 |
| | EXCRETION . III-11 |
| | DISCUSSION III-14 |
| | SUMMARY III-16 |
| | IV. HUMAN EXPOSURE . IV-1 |
| | V. HEALTH EFFECTS IN ANIMALS . V-1 |
| | INTRODUCTION V-1 |
| | SHORT-TERM EXPOSURE . V-1 |
| | OTHER SHORT-TERM EFFECTS V-15 |
| | LONG-TERM EXPOSURE V-16 |
| | DEVELOPMENTAL TOXICITY . V-20 |
| | REPRODUCTIVE TOXICITY . V-21 |
| | MUTAGENECITY . V-23 |
| | CARCINOGENICITY . V-26 |
| | SUMMARY AND DISCUSSION . V-31 |
| | VI. HEALTH EFFECTS IN HUMANS . VI-1 |
| | INTRODUCTION VI-1 |
| | CLINICAL REPORTS AND EXPERIMENTS . VI-1 |
| | EPIDEMIOLOGY STUDIES VI-4 |
| | HIGH-RISK SUBPOPULATIONS . VI-6 |
| | SUMMARY AND DISCUSSION . VI-7 |
| | VII. MECHANISMS OF TOXICITY VII-1 |
| | GENERAL THEORIES . VII-1 |
| | SUMMARY VII-3 |
| | VIII. QUANTIFICATION OF TOXICOLOGIC EFFECTS VIII-1 |
| | INTRODUCTION VIII-1 |
| | CURRENT LEVELS OF EXPOSURE VIII-7 |
| | NONCARCINOGENIC EFFECTS . VIII-7 |
| | QUANTIFICATION OF NONCARCINOGENIC EFFECTS VIII-14 |
| | Derivation of 1-Day Health Advisory VIII-14 |
| | Derivation of 10-Day Health Advisory . VIII-15 |
| | Derivation of Longer-term HA . VIII-16 |
| | Assessment of Lifetime Exposure and Derivation of a DWEL VIII-17 |
| | CARCINOGENIC EFFECTS . VIII-19 |
| | EXISTING GUIDELINES, RECOMMENDATIONS AND STANDARDS VIII-21 |
| | SPECIAL GROUPS AT RISK VIII-21 |
| | RISK CHARACTERIZATION . VIII-22 |
| | REFERENCES . IX-1 |